We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$6.71B
AUM Growth
+$2.5B
(+59%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
30.61%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
2,565
New
44
Increased
937
Reduced
347
Closed
1,235
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.8M |
| 2 |
Microsoft
MSFT
|
+$58.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$56.5M |
| 4 |
ExxonMobil
XOM
|
+$46.3M |
| 5 |
Chevron
CVX
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$4.89M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$3.48M |
| 3 |
NYX
NYSE EURONEXT INC
NYX
|
+$3.27M |
| 4 |
CoStar Group
CSGP
|
+$2.8M |
| 5 |
VPHM
VIROPHARMA INC
VPHM
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.32% |
| 2 | Technology | 15.24% |
| 3 | Healthcare | 12.35% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Cheniere Energy
LNG
$56.5B
| $581K | 0.01% |
13,463
+3,413
| +34% | +$136K |
|
1052
Exelixis
EXEL
$13.9B
| $580K | 0.01% |
94,538
-86,233
| -48% | -$475K |
|
1053
H.B. Fuller
FUL
$3B
| $579K | 0.01% |
11,131
-24,779
| -69% | -$1.21M |
|
1054
Ironwood Pharmaceuticals
IRWD
$611M
| $577K | 0.01% |
59,355
-50,801
| -46% | -$456K |
|
|
PRA
1055
DELISTED
ProAssurance
PRA
| $574K | 0.01% |
11,846
-898
| -7% | -$41.9K |
|
|
CHMT
1056
DELISTED
Chemtura Corporation
CHMT
| $573K | 0.01% |
20,540
-47,483
| -70% | -$1.19M |
|
1057
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $572K | 0.01% |
5,011
| – | – |
|
|
MANT
1058
DELISTED
Mantech International Corp
MANT
| $563K | 0.01% |
18,818
+1,632
| +9% | +$46.6K |
|
1059
Ligand Pharmaceuticals
LGND
$6.02B
| $552K | 0.01% |
16,807
-12,743
| -43% | -$415K |
|
|
ATHN
1060
DELISTED
Athenahealth, Inc.
ATHN
| $542K | 0.01% |
4,027
-19,808
| -83% | -$2.55M |
|
1061
Popular Inc
BPOP
$11B
| $541K | 0.01% |
18,824
-229
| -1% | -$6.19K |
|
1062
Novavax
NVAX
$1.23B
| $539K | 0.01% |
5,268
-1,946
| -27% | -$137K |
|
1063
Community Bank
CBU
$3.53B
| $536K | 0.01% |
13,502
-19,751
| -59% | -$730K |
|
1064
Provident Financial Services
PFS
$3.11B
| $530K | 0.01% |
27,416
-27,042
| -50% | -$498K |
|
|
AUXL
1065
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $527K | 0.01% |
25,432
-23,058
| -48% | -$435K |
|
1066
Marvell Technology
MRVL
$174B
| $521K | 0.01% |
36,262
+6,975
| +24% | +$89.8K |
|
1067
Tootsie Roll Industries
TR
$2.82B
| $518K | 0.01% |
23,378
+2,651
| +13% | +$57.6K |
|
1068
BOK Financial
BOKF
$8.64B
| $515K | 0.01% |
7,760
+1,048
| +16% | +$66.3K |
|
|
VVUS
1069
DELISTED
Vivus Inc
VVUS
| $503K | 0.01% |
5,537
-4,628
| -46% | -$447K |
|
1070
Core Laboratories
CLB
$538M
| $500K | 0.01% |
2,620
+697
| +36% | +$130K |
|
|
BPFH
1071
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $490K | 0.01% |
38,829
-35,534
| -48% | -$412K |
|
1072
Altisource Portfolio Solutions
ASPS
$65.4M
| $487K | 0.01% |
384
-8
| -2% | -$9.65K |
|
1073
Align Technology
ALGN
$12B
| $483K | 0.01% |
8,454
-41,104
| -83% | -$2.21M |
|
1074
RLI Corp
RLI
$5.68B
| $481K | 0.01% |
19,760
-48,288
| -71% | -$1.15M |
|
|
MNTA
1075
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $476K | 0.01% |
26,942
-22,267
| -45% | -$374K |
|
Similar funds
ProShare Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, ProShare Advisors held 2,565 positions worth $6.71B, up 59% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
ProShare Advisors deployed $2.05B of net new capital in Q4 2013, opening 44 new positions and adding to 937 existing holdings. Its largest new stake was VEON: 13,524 shares worth $4.38M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was CoStar Group, an estimated $2.8M trimmed.
- ProShare Advisors's largest Q4 2013 buy was VEON: 13,524 shares worth $4.38M.
- ProShare Advisors added most to Apple in Q4 2013, an estimated $92.8M increase.
- ProShare Advisors's biggest Q4 2013 reduction was CoStar Group, cutting an estimated $2.8M.
- ProShare Advisors fully exited DELL INC in Q4 2013, selling an estimated $4.89M.
- ProShare Advisors's ten largest holdings make up 15% of its $6.71B portfolio in Q4 2013.
- ProShare Advisors opened 44 new positions and closed 1,235 in Q4 2013.
- ProShare Advisors's portfolio value rose 59% quarter-over-quarter to $6.71B.
Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.